Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Aerocrine's Portable Asthma Monitor Launched in France, China

By HospiMedica staff writers
Posted on 24 Dec 2007
Aerocrine AB (Solna, Sweden) has granted Phadia France (Montigny le Bretonneux, France) the right to market and sell Niox Mino on the French market. More...


Phadia, a company that specializes in allergy diagnostics, already sells Aerocrine products in Spain. Phadia will begin selling Niox Mino on January 1, 2008. Niox Mino is a non-invasive portable device, which monitors asthma treatment by measuring patients' exhaled nitric acid.

In France, about four million people have diagnosed asthma and the prevalence of asthma- like symptoms is even higher--about 15%. "Phadia has an established market position in France in addition to good knowledge of our products.” said Paul de Potocki, CEO of Aerocrine. "We look forward to working together with Phadia to launch Aerocrine's products in France.”

The Chinese registration authority also approved Aerocrine's Niox products and the company has entered into a distribution agreement with Bioson, Inc. (Beijing, China), which includes sales of both Niox and Niox Mino in China.

Aerocrine is a clinically based medical technology corporation that develops improved asthma management and care products. The company markets Niox Flex worldwide and is now marketing Niox Mino, a new generation of handheld asthma devices, in Europe and China. Both products are tailored for rapid, noninvasive control of the inflammatory status in the airways, and may play a critical role for optimized asthma care and disease control.


Related Links:
Aerocrine
Phadia France
Bioson

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.